BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and ...
Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded. And I would now like to introduce ...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a conference call and webcast on ...
Welcome to the Lineage Cell Therapeutics Third (sic) [ Fourth ] Quarter 2025 Conference Call. [Operator Instructions] An audio webcast of this call is available on the Investors section of Lineage's ...
Brainstorm Cell Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter ...
Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this call is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results